CompletedNot Applicable

Efficacy of C-PRF vs i-PRF in Thin Gingival Biotype Subjects

Iraq10 participantsStarted 2022-02-01

Plain-language summary

Randomized split mouth clinical trials study focused on comparing the efficacy of i-prf versus c-prf injections on gingival thickness and keratinized tissue width in subjects with thin gingival biotype.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥18 years and no systemic disease or pregnancy.
✓. Non-smoker.
✓. Subjects with clinically healthy intact periodontium; bleeding on probing (BOP)\<10%, probing pocket depth (PPD)≤3mm, intact periodontium (no probing attachment loss). (Chapple et al., 2018).
✓. Four non-adjacent sites of anterior region with thin gingival biotype (GT ≤ 1mm). (Patrick H. et al., 2018).
✓. No malocclusion, crowding, filling, missing or supernumerary mandibular anterior teeth.
✓. No blood-borne conditions.
✓. Any symptoms of recent acute illness e.g., COVID-19.

Exclusion criteria

✕. Active orthodontic treatment.
✕. Previous periodontal surgery.
✕. Use of blood thinners.
✕. Use of any drugs that might lead to gingival enlargement.
✕. Attrition.
✕. Gingival Recession.
✕. Thick gingival biotype.

What they're measuring

measure the mean differences gain of GT&KTW

Timeframe: baseline and 3 months

Trial details

NCT IDNCT05615155

SponsorSajjad Ahmed Shakir

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-11-01

View on ClinicalTrials.gov More Thin Gingival Biotype trials